Eisa, N., Alshehri, A., Assiri, M. (2021). COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review. Research in Oncology, 17(2), 80-85. doi: 10.21608/resoncol.2021.51731.1128
Noha Eisa; Abdulrahman Alshehri; Mohammed Assiri. "COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review". Research in Oncology, 17, 2, 2021, 80-85. doi: 10.21608/resoncol.2021.51731.1128
Eisa, N., Alshehri, A., Assiri, M. (2021). 'COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review', Research in Oncology, 17(2), pp. 80-85. doi: 10.21608/resoncol.2021.51731.1128
Eisa, N., Alshehri, A., Assiri, M. COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review. Research in Oncology, 2021; 17(2): 80-85. doi: 10.21608/resoncol.2021.51731.1128
COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review
1Hemato-Oncology Department, Aseer Central Hospital, Abha, Saudi Arabia
2Clinical Hematology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Abstract
Chronic lymphocytic leukemia (CLL) typically occurs in the elderly and has a highly variable clinical course. Infectious complications have been known to be a major cause of morbidity and mortality in CLL patients. The management of hematological malignancies, including CLL, during the COVID-19 pandemic is challenging. Here we describe two patients with CLL who got infected with SARS-COV-2 as confirmed by positive nasopharyngeal swab PCR. The 1st patient, who was receiving treatment for CLL-associated autoimmune hemolytic anemia, was hospitalized with mild COVID-19 symptoms. The 2nd patient, who was on active treatment for CLL, had asymptomatic COVID-19 infection and was not hospitalized. Both patients recovered from COVID-19 without related complications.
View on SCiNiTO
Top